Enterprise Estonia supported the project "Development of a POC test for rapid diagnosis of pathogens (incl. COVID-19)". The project period is 01.02.2021-31.12.2023.
So far, Solis BioDyne has offered the gold standard solutions for diagnostics- RT-qPCR. Now, SARS-CoV-2 has highlighted the need for a wider variety of methods for COVID-19 analysis of patient samples.
As part of the European Regional Development Fund-supported project, Solis BioDyne is developing an innovative isothermal polymerase from which a number of reagents are being developed for use in various methods. Isothermal polymerases are increasingly used in close-up patient studies for the rapid analysis of various pathogens, allowing the analysis to be performed within 30 minutes without complex equipment.
The second goal of the project is the development of freeze-drying technology for Solis BioDyne products. Freeze-drying makes it possible to significantly extend the shelf life of products and to create new types of analytical methods. The total cost of the project is 1,368,200 €, of which the European Regional Development Fund covers up to 1,094,560€.
We are having a stability appreciation month, so here are all the good things related to stability from experiment set-up to logistics.
In our last story we talked about how animals can help to improve human health. This time we are talking about how humans could improve the health of animals, more specifically the health of horses and donkeys.
During the last couple of years PCR tests have become quite well-known, mostly in relation to the COVID-19. In reality, using PCR tests to diagnose diseases has been around for some time and it’s becoming increasingly more popular and diverse, allowing for better pathogen detection not just in the field of medicine, but also in other areas such as agriculture.
It is time to introduce another one of our amazing colleagues. For this month we have chosen our development and technology specialist Ilja.
